<DOC>
	<DOCNO>NCT01926860</DOCNO>
	<brief_summary>The present study explore whether simultaneously give hepatitis A vaccine ( Epaxal ) impact immune response PCV13 ( pneumococcal conjugate vaccine ; Prevenar13 ) vaccine adult . The immune response PCV13 measure level serotype specific serum antibody opsonophagocytic activity . The result volunteer receive PCV13 Epaxal compare control group adults receive either hepatitis A PCV13 vaccine .</brief_summary>
	<brief_title>PCV13 + Hepatitis A Vaccine Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1 . Male female subject age ≥50 2 . General good health establish medical history physical examination 3 . Written inform consent 4 . Females childbearing potential must agree use efficacious hormonal barrier method birth control study . Abstinence acceptable . 5 . Available visit schedule study . 6 . No previous Pnc vaccination 7 . No previous hepatitis A vaccine 8 . No vaccine administer 30 day prior study 1 . Previous pneumococcal hepatitis A vaccination 2 . Immunization vaccine ( oral parenteral ) within 4 week prior study start plan vaccination study 3 . Chronic administration immunosuppressant immunemodifying drug within 6 month first dose vaccine ; patient use oral corticosteroid dosage ≥0.5 mg/kg/d prednisolone equivalent exclude ; inhale topical steroid allow 4 . Any confirmed suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection 5 . Pregnancy lactation 6 . Acute disease time enrollment ( define presence moderate severe illness without fever ( fever define body temperature ≥38 °C ) . 7 . Alcohol drug abuse 8 . Suspected noncompliance 9 . Use investigational drug within 30 day precede study vaccine , plan use study period 10 . Any clinically significant history know suspected anaphylaxis hypersensitivity reaction base judgement investigator 11 . Employee investigational site , relative spouse investigator 12 . Any criterion , investigator 's opinion , would compromise ability subject participate study , subject 's wellbeing , outcome study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Prevenar13</keyword>
	<keyword>pneumococcal conjugate vaccine</keyword>
	<keyword>Epaxal</keyword>
	<keyword>hepatitis A vaccine</keyword>
</DOC>